Pfizer Inc. (PFE)

Pfizer Inc., adjusted current assets

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current assets
	Adjustments
	Add: Allowance for doubtful accounts
	Less: Current deferred tax assets (included in Current deferred tax assets and other current tax assets)1
	After Adjustment
	Adjusted current assets

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Pfizer Inc., adjusted total assets

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total assets
	Adjustments
	Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
	Add: Allowance for doubtful accounts
	Less: Current deferred tax assets (included in Current deferred tax assets and other current tax assets)2
	Less: Noncurrent deferred tax assets (included in Noncurrent deferred tax assets and other noncurrent tax assets)3
	After Adjustment
	Adjusted total assets

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Pfizer Inc., adjusted current liabilities

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current liabilities
	Adjustments
	Less: Current deferred tax liabilities (included in Other current liabilities)1
	Less: Current restructuring accruals
	After Adjustment
	Adjusted current liabilities

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Pfizer Inc., adjusted total liabilities

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total liabilities
	Adjustments
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Less: Current deferred tax liabilities (included in Other current liabilities)2
	Less: Noncurrent deferred tax liabilities3
	Less: Restructuring accruals
	After Adjustment
	Adjusted total liabilities

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Pfizer Inc., adjusted total Pfizer Inc. shareholders’ equity

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total Pfizer Inc. shareholders’ equity
	Adjustments
	Less: Net deferred tax asset (liability)1
	Add: Allowance for doubtful accounts
	Add: Restructuring accruals
	Add: Equity attributable to noncontrolling interests
	After Adjustment
	Adjusted total Pfizer Inc. shareholders’ equity

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Pfizer Inc., adjusted capitalization table

US$ in millions

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Short-term borrowings, including current portion of long-term debt
	Long-term debt, excluding current portion
	Total reported debt
	Total Pfizer Inc. shareholders’ equity
	Total reported capital
	Adjustments to Debt
	Add: Operating lease liability (before adoption of FASB Topic 842)1
	Adjusted total debt
	Adjustments to Equity
	Less: Net deferred tax asset (liability)2
	Add: Allowance for doubtful accounts
	Add: Restructuring accruals
	Add: Equity attributable to noncontrolling interests
	Adjusted total Pfizer Inc. shareholders’ equity
	After Adjustment
	Adjusted total capital

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Pfizer Inc., adjusted net income attributable to Pfizer Inc.

US$ in millions

	12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Net income attributable to Pfizer Inc.
	Adjustments
	Add: Deferred income tax expense (benefit)1
	Add: Increase (decrease) in allowance for doubtful accounts
	Add: Increase (decrease) in restructuring accruals
	Less: Discontinued operations, net of tax
	Add: Other comprehensive income (loss) before allocation to noncontrolling interests
	Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
	After Adjustment
	Adjusted net income attributable to Pfizer Inc.

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).